Post Profile






Recycling approved drugs for cancer treatment

In recent years, it has become a medical trend to do research on well-known drugs, to discover unknown effects. This strategy is called repurposing. Now researchers have found that a drug against kidney cancer can possibly fight several types of cancer.
read more

share

Related Posts


Key Cellular Enzyme Could Be Effective Drug Target in Urologic Cancer Cells

Health : Newswise Medical News

Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.

St. Jude Children's Research Hospital Discovery Aided Quest For Adult Cancer Drug

Health : Medical News Today

A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights ho...

New More Effective Treatment Option for Breast Cancer Patients Approved by FDA

Health : Newswise Medical News

Rush University Medical Center researchers participated in clinical trials for promising new drug against aggressive breast cancer called Kadcyla also known as TDM-1 (traztuzumab emtansine).

New HIF-2 Kidney Cancer Therapy More Effective Than Current Treatment, Study Shows

Health : Newswise Medical News

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Ca...

New HIF-2 kidney cancer therapy more effective than current treatment, study shows

Diseases & Conditions / Cancer : EurekAlert: Cancer

(UT Southwestern Medical Center) A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at H...

Comments


Copyright © 2016 Regator, LLC